Equillium, Inc. (EQ) financial statements (2023 and earlier)

Company profile

Business Address 2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments, including:80,70082,20053,10065,900
Cash and cash equivalents50,36623,98213,21928,509
Short-term investments30,34558,18139,92437,405
Other undisclosed cash, cash equivalents, and short-term investments(11)37(43)(13)
Other undisclosed current assets2,6702,9742,3311,199
Total current assets:83,37085,17455,43167,099
Noncurrent Assets
Operating lease, right-of-use asset1,645  
Property, plant and equipment2372399364
Other noncurrent assets1531515 
Total noncurrent assets:2,03525410864
TOTAL ASSETS:85,40585,42855,53967,163
Current Liabilities
Accounts payable and accrued liabilities7,1115,5793,8832,028
Accounts payable1,2252,7661,8731,119
Accrued liabilities5,8862,8132,010909
Other undisclosed current liabilities376   
Total current liabilities:8,9157,2453,8832,028
Noncurrent Liabilities
Long-term debt and lease obligation1,2358,2759,681 
Long-term debt, excluding current maturities 8,2759,681 
Operating lease, liability1,235  
Liabilities, other than long-term debt 54127200
Other liabilities 54127200
Other undisclosed noncurrent liabilities7,515   
Total noncurrent liabilities:9,9858,3299,808200
Total liabilities:18,90015,57413,6912,228
Stockholders' equity
Stockholders' equity attributable to parent66,50569,85441,84864,935
Common stock2211
Additional paid in capital176,618141,07482,93880,441
Accumulated other comprehensive income (loss)(138)(297)215
Accumulated deficit(109,977)(70,925)(41,112)(15,512)
Total stockholders' equity:66,50569,85441,84864,935
TOTAL LIABILITIES AND EQUITY:85,40585,42855,53967,163

Income statement (P&L) ($ in thousands)

Operating expenses(37,786)(29,548)(26,727)(8,616)
Operating loss:(37,786)(29,548)(26,727)(8,616)
Nonoperating income (expense)(1,266)(265)1,127(4,635)
Investment income, nonoperating574761,391340
Other nonoperating income (expense)(250)35815 
Interest and debt expense(1,073)(1,099)(279)(2,558)
Other undisclosed income from continuing operations before equity method investments, income taxes 1,099279 
Loss from continuing operations before equity method investments, income taxes:(40,125)(29,813)(25,600)(15,808)
Other undisclosed income from continuing operations before income taxes1,073   
Loss before gain (loss) on sale of properties:(39,052)(29,813)(25,600)(15,808)
Other undisclosed net income   2,558
Net loss available to common stockholders, diluted:(39,052)(29,813)(25,600)(13,250)

Comprehensive Income ($ in thousands)

Net loss:(39,052)(29,813)(25,600)(13,250)
Other comprehensive income (loss)159(318)16 
Comprehensive loss:(38,893)(30,131)(25,584)(13,250)
Other undisclosed comprehensive income, net of tax, attributable to parent   5
Comprehensive loss, net of tax, attributable to parent:(38,893)(30,131)(25,584)(13,245)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: